| Not Yet Recruiting | CABOTEGRAVIR/LENACAPAVIR DUAL LONG ACTING THERAPY (COHORT IMEA 074) CABOTEGRAVIR, LENACAPAVIR | — | 2026-03-15 |
| Not Yet Recruiting | Real World Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide(BIC/FTC/TAF) in PLWH in Precarity HIV-1, Public Universal Healthcare Insurance Coverage, BIC/FTC/TAF | — | 2025-09-01 |
| Withdrawn | CAbotégravir LENacapavir DUal Long Acting HIV1 Infection, Multi-treated Patients Who Have Received Multiple Lines of Antiretroviral Treatment, CABOTEGRAVIR | Phase 2 | 2025-01-15 |
| Not Yet Recruiting | Mobile Outreach Screening of High-Risk Human Papillomavirus Infection in Women with Limited Access to Health S Women's Health: Cervical Neoplasm | N/A | 2024-12-01 |
| Not Yet Recruiting | Determination of New Detection and Quantification Thresholds for Serological and Molecular Tests for Hepatitis Delta Hepatitis | N/A | 2024-11-30 |
| Active Not Recruiting | Cohort IMEA 070 -Lenacapavir Compassional HIV Infections | — | 2024-04-01 |
| Completed | "Observational Study on Tolerability and Observance of Post-exposure Prophylaxis With Doravirine in HIV Viral HIV Infections | — | 2023-06-08 |
| Unknown | Pharmacokinetics of Calcineurin & mTOR Inhibitors in HIV-1 Infected Kidney Transplant Recipients After Switch HIV-infected Patient Kidney Transplant Recipient | Phase 4 | 2022-09-29 |
| Completed | Assess the Performance of Metagenomic Sequencing in the Diagnosis of STI (NGS-IST) Sexually Transmitted Infections (Not HIV or Hepatitis), Chlamydia Trachomatis Infection, Neisseria Gonorrhoeae Infection | N/A | 2022-07-11 |
| Unknown | Evaluation of an Adaptative, Multidisciplinary, Reach-out Program, Facilitating Pre Exposition HIV Prophylaxis Transgenderism | — | 2022-07-01 |
| Unknown | Switch to TAF+FTC+BIC in HIV-1-infected Patients Over 65 Years Old at Risk of Polymedication HIV Infections | Phase 4 | 2020-08-17 |
| Unknown | Initiation of First-line Antiretroviral Treatment With TENOFOVIR ALAFENAMIDE - EMTRICITABINE - BICTEGRAVIR at HIV Seropositivity | Phase 4 | 2019-11-18 |
| Completed | Risk-factors for Multidrug-resistant Bacteria Colonization Among Patients at High Risk of STIs Bacterial Infections, HIV Infections | — | 2018-05-11 |
| Completed | Short Duration Therapy of Acute Hepatitis C Genotypes 1 or 4 Acute Hepatitis C, HIV | Phase 2 | 2017-05-31 |
| Completed | Kinetics of HIV-RNA Decay in Seminal Plasma of Men Treated by Dolutegravir at the Time of Primary HIV Infectio HIV Infection Primary | Phase 3 | 2017-01-01 |
| Unknown | French HIV-HBV Cohort Hepatitis B, HIV, Liver Cirrhosis | — | 2016-10-01 |
| Completed | Pharmacokinetic Study of the Association of Amoxicillin / Clavulanic Acid to Obese Adults Obesity | Phase 1 / Phase 2 | 2015-07-24 |
| Completed | Pilot Study Evaluating the Use of Simultaneous HBV, HCV, and HIV Rapid Tests HIV, Hepatitis B, Hepatitis C | N/A | 2013-02-01 |
| Unknown | Rosuvastatin to Decrease Residual Immune Activation in HIV Infection HIV-1 Infection | Phase 2 | 2012-03-01 |
| Completed | Application of HBV Rapid Tests as a Tool for Wide-Use Screening Hepatitis B, Liver Cirrhosis, Carcinoma, Hepatocellular | N/A | 2012-02-01 |
| Completed | Evaluation of the Efficacy and Safety Between Two Antiretroviral Regimens, in HIV-1-infected Treatment-naïve S HIV-1 Infection, Immunosuppression-related Infectious Disease | Phase 4 | 2011-02-23 |
| Completed | Evaluation of Liver Fibrosis in HIV-infected Patients With Metabolic Syndrome Abdominal Obesity Metabolic Syndrome, HIV, Liver Fibrosis | — | 2011-01-01 |
| Completed | Comparison of Treatment Simplification by LPV/r vs Current Treatment Continuation in HIV-Infected Patients HIV Infections | Phase 3 | 2005-10-01 |